메뉴 건너뛰기




Volumn 24, Issue 4, 2009, Pages 288-294

Trials of cardiovascular risk factor management in type 2 diabetes

Author keywords

Aspirin; Blood glucose; Blood pressure; Diabetes; Lipids

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; BENAZEPRIL; CAPTOPRIL; FENOFIBRATE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE PLUS PERINDOPRIL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RAMIPRIL; TELMISARTAN; ANTITHROMBOCYTIC AGENT; GLUCOSE BLOOD LEVEL;

EID: 67651160491     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32832a7b01     Document Type: Review
Times cited : (3)

References (14)
  • 1
    • 40249120466 scopus 로고    scopus 로고
    • Standards of medical care in diabetes - 2008
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31 (Suppl 1):S12-S54.
    • (2008) Diabetes Care , vol.31 , Issue.SUPPL. 1
  • 2
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Along with the ADVANCE trial, this study provides the most reliable evidence about the effects of intensive glucose control on cardiovascular events
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559. Along with the ADVANCE trial, this study provides the most reliable evidence about the effects of intensive glucose control on cardiovascular events.
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 3
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
    • (2008) N Engl J Med , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 4
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril, or both in patients at high risk for vascular events
    • The ONTARGET Investigators. This is the first large-scale trial to address the issue of dual RAAS inhibition in patients with diabetes
    • The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547-1559. This is the first large-scale trial to address the issue of dual RAAS inhibition in patients with diabetes.
    • (2008) N Engl J Med , vol.358 , pp. 1547-1559
  • 5
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • ADVANCE Collaborative Group
    • ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-840.
    • (2007) Lancet , vol.370 , pp. 829-840
  • 6
    • 53749091595 scopus 로고    scopus 로고
    • Long-term follow-up after tight control of blood pressure in type 2 diabetes
    • Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359:1565-1576.
    • (2008) N Engl J Med , vol.359 , pp. 1565-1576
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3
  • 7
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • The Advance Collaborative Group. This is the largest trial to date addressing the effects of intensive glucose control in type 2 diabetes, and together with ACCORD provides the most reliable evidence
    • The Advance Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572. This is the largest trial to date addressing the effects of intensive glucose control in type 2 diabetes, and together with ACCORD provides the most reliable evidence.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 8
    • 44349101152 scopus 로고    scopus 로고
    • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336:1121-1123.
    • (2008) BMJ , vol.336 , pp. 1121-1123
  • 9
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-139.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 10
    • 53749096863 scopus 로고    scopus 로고
    • 10-year follow-up of intensive glucose control in type 2 diabetes
    • This long-term observational follow-up of the UKPDS has raised the possibility that beneficial effects of intensive glucose control may only become apparent many years after the intervention
    • Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359:1577-1589. This long-term observational follow-up of the UKPDS has raised the possibility that beneficial effects of intensive glucose control may only become apparent many years after the intervention.
    • (2008) N Engl J Med , vol.359 , pp. 1577-1589
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3
  • 11
    • 38049033935 scopus 로고    scopus 로고
    • Efficacy of cholesterollowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: A meta-analysis
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterollowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117-125.
    • (2008) Lancet , vol.371 , pp. 117-125
  • 12
    • 56149113603 scopus 로고    scopus 로고
    • Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial
    • Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008; 300:2134-2141.
    • (2008) JAMA , vol.300 , pp. 2134-2141
    • Ogawa, H.1    Nakayama, M.2    Morimoto, T.3
  • 13
    • 54949131747 scopus 로고    scopus 로고
    • The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
    • doi: 10.1136/bmj.a840
    • Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337:a1840. doi: 10.1136/bmj.a840.
    • (2008) BMJ , vol.337
    • Belch, J.1    MacCuish, A.2    Campbell, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.